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ABSTRACT Despite their structural resemblance, a pair of cyclic halogenated compounds, 1 -chloro-1 ,2,2-trifluorocyclobu-
tane (F3) and 1,2-dichlorohexafluorocyclobutane (F6), exhibit completely different anesthetic properties. Whereas the former
is a potent general anesthetic, the latter produces no anesthesia. Two linear compounds, isoflurane and 2,3-dichlorooct-
ofluorobutane (F8), although not a structural pair, also show the same anesthetic discrepancy. Using 19F nuclear magnetic
spectroscopy, we investigated the time-averaged submolecular distribution of these compounds in a vesicle suspension of
phosphatidylcholine lipids. A two-site exchange model was used to interpret the observed changes in resonance frequencies
as a function of the solubilization of these compounds in membrane and in water. At clinically relevant concentrations, the
anesthetics F3 and isoflurane distributed preferentially to regions of the membrane that permit easy contact with water. The
frequency changes of these two anesthetics can be well characterized by the two-site exchange model. In contrast, the
nonanesthetics F6 and F8 solubilized deeply into the lipid core, and their frequency change significantly deviated from the
prediction of the model. It is concluded that although anesthetics and nonanesthetics may show similar hydrophobicity in bulk
solvents such as olive oil, their distributions in various regions in biomembranes, and hence their effective concentrations at
different submolecular sites, may differ significantly.
INTRODUCTION
The Meyer-Overton rule, that the potency of general anes-
thetics correlates strongly with their solubility in olive oil,
has long been taken to indicate that the sites of action of
general anesthetics, whether in the membrane lipid or in
excitable proteins, are hydrophobic in nature (Alifimoff and
Miller, 1992; Franks and Lieb, 1994; Taheri et al., 1991;
Ueda, 1995). Recent studies (Koblin et al., 1994; Liu et al.,
1994a,b; Taheri et al., 1993), however, have shown that
many compounds, strikingly similar to potent general anes-
thetics and predicted by the Meyer-Overton rule to be
anesthetics, are completely devoid of anesthetic effects (i.e.,
they produce no anesthesia when administered alone and do
not decrease the requirement for conventional anesthetics;
Koblin et al., 1994). Although deviation from the prediction
by the Meyer-Overton rule has been observed in the potency
"cutoff' phenomenon found in many homologous series of
anesthetics (Alifimoff et al., 1989; Liu et al., 1994a; Raines
et al., 1993), the availability of anesthetic and nonanesthetic
pairs that resemble each other structurally permits a closer
examination of the molecular characteristics shared by the
anesthetics but not by the nonanesthetics. Such examination
may shed new light on the molecular and cellular mecha-
nisms of general anesthesia (Raines and Miller, 1994).
Among many novel anesthetic and nonanesthetic pairs
are two halogenated cyclobutanes, 1-chloro-1,2,2-trifluoro-
cyclobutane (F3) and 1,2-dichlorohexafluorocyclobutane
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(F6). These two compounds have a similar molecular shape
and size, and according to the Meyer-Overton rule, both
should be potent general anesthetics, with predicted mini-
mum alveolar concentrations (MAC) in rats of 0.0073 and
0.042 atm (Koblin et al., 1994), respectively. The measured
MAC for F3, however, is 0.014 atm, and no anesthetic
effects of F6 have been found, despite the fact that it
dissolves in tissues and penetrates into the central nervous
system at concentrations exceeding the predicted MAC
(Koblin et al., 1994). Similarly, in linear compounds, some
halogenated butanes produce anesthesia (Bagnall et al.,
1979; Eger et al., 1994; Robbins, 1946), whereas others do
not. Of particular interest to us is 2,3-dichlorooctofluorobu-
tane (F8), which has a predicted MAC in rats of 0.073 atm
(Koblin et al., 1994; Liu et al., 1994a) but produces no
anesthesia.
The pharmacological difference between anesthetics and
nonanesthetics may result from their distinct submolecular
distribution in neuronal membranes. It has been shown that
some anesthetics (e.g., enflurane, methoxyflurane, halo-
thane, and chloroform) distribute preferentially at the mem-
brane interface (Kamaya et al., 1981; Kaneshina et al.,
1981; Yokono et al., 1981, 1989; Yoshida et al., 1989) and
that they do not mix isotropically with the lipid core
(Kaneshina et al., 1981). It has also been demonstrated for
n-alkane anesthetics (Liu et al., 1994b) that the product of
MAC X oil/gas partition coefficient X saline/gas partition
coefficient is more constant than that of MAC X oil/gas
partition coefficient predicted by the Meyer-Overton rule,
suggesting that the site of anesthetic action may be neither
purely hydrophobic nor purely hydrophilic, but a combina-
tion of the two (Liu et al., 1994b). Indeed, using intermo-
lecular heteronuclear Overhauser effects, we have found
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that xenon, a monatomic anesthetic that is purely apolar in
the gas phase, interacts preferentially with the amphiphilic
regions after dissolving into a model membrane (Tang and
Xu, 1994; Xu and Tang, 1997). Nonanesthetics, on the other
hand, have relatively high oil/saline partition coefficients
and thus tend to partition into the core of the membrane
lipid.
In the present study, the anesthetic compounds isoflurane
and F3, and the nonanesthetic compounds F6 and F8 were
equilibrated at clinically relevant concentrations with a
phosphatidylcholine (PC) model membrane. Their time-
averaged distributions in the model membrane were exam-
ined at both 20°C and 37°C, using 19F nuclear magnetic
resonance (NMR) spectroscopy. The anesthetics were found
to dwell, on the NMR time scale, in regions more accessible
to (or easily exchangeable with) water, whereas the non-
anesthetics partitioned into the deeper core of the membrane.
MATERIALS AND METHODS
Materials
Lyophilized L-a-PC from egg yolk (purity > 99%) was obtained from
Avanti Polar Lipids (Alabaster, AL). Compounds F3, F6 (in a 1:1.2
mixture of trans- and cis-isomers), and F8 (in a mixture of five different
conformational isomers with unknown ratios) were purchased from PCR
(Gainesville, FL); isoflurane (AErrane) was from Ohmeda PPD (Liberty
Corner, NJ); and deuterium oxide (D20) was from Cambridge Isotope
Laboratories (Woburn, MA). Other chemicals, of analytical reagent grade,
were purchased from Sigma (St. Louis, MO). All agents were used without
further purification.
Sample preparation
Phosphatidylcholine lipid vesicles were prepared as previously described
(Smith et al., 1981). Briefly, measured amounts of lyophilized egg PC were
dissolved in chloroform and subsequently dried into a thin film under a
stream of N2 gas. The chloroform residues were further removed by
applying a high vacuum at room temperature for at least 2 h. Thereafter,
distilled and deionized water was added to make a homogeneous PC
suspension with a final lipid concentration of 80 mg/ml (- 105 mM). The
suspension was subsequently sonicated into vesicles - 170 nm in diameter,
as determined by light scattering (NICOMP 270 submicron particle ana-
lyzer; Particle Sizing System, Santa Barbara, CA).
All NMR samples were prepared by mixing measured amounts of PC
vesicles (with final lipid concentrations ranging from 0 to 32 mM), fluor-
inated compounds, H20, and D20 (20% by volume for the purpose of
deuterium lock) directly inside the 5-mm, high-precision NMR tubes
(Wilmad Glass Co., Buena, NJ), which have a volume of 2.5 ml. High-
precision, gas-tight microsyringes (Hamilton Co., Reno, NV) were used to
measure either 0.6 ,ul of F3, 0.8 ,ul of F6, 0.7 ,ul of isoflurane, or 0.4 ,ul of
F8 for each NMR sample, resulting in final nominal concentrations of 1.0
mM for F8 and 2.2 mM for F3, F6, and isoflurane. To minimize possible
losses of these volatile fluorinated compounds, the tubes were almost
completely filled, and rapidly capped and sealed with a paraffin film. A
tiny air bubble, <1% of the tube volume, was left in the tubes for the
purpose of inversion mixing. After vigorous mixing, the samples were
allowed to equilibrate at 40C for at least 24 h before NMR measurements.
Complete dissolution was confirmed by NMR, as the undissolved beads of
these compounds precipitate and give rise to distinct NMR spectral peaks.
NMR spectroscopy
'9F NMR experiments were conducted at both 20°C and 37°C, using an
Otsuka-Chemagnetics (Fort Collins, CO) CMXW-400SLI spectrometer
operating at 377.4 MHz. A four-nucleus probe (J S Research, Boston, MA),
with an observation channel for '9F, was used to enhance the detection
sensitivity. A one-pulse sequence was employed with a nominal 900 flip
angle of 29 [Ls, a repetition delay of 3.5 s, and a spectral width of 10-25
kHz. Typically, 16K complex data points were collected and zero filled
once before Fourier transformation. For each series of samples with a given
fluorinated compound, changes in resonant frequencies were measured in
units of hertz as a function of PC concentrations. Such changes were all
relative to the corresponding peaks of the same compound in the PC-free
samples and analyzed as follows.
Chemical shift analysis
For any given fluorinated molecules, the resonant frequency (i.e., the
chemical shift) of resonance peaks for each given '9F nucleus may vary,
depending on the microscopic molecular environment that the nucleus
experiences. In a water suspension of PC vesicles, the microscopic envi-
ronment differs from site to site, permitting determination of distribution of
the fluorinated molecules at different sites based on changes in the resonant
frequencies. In the limit of rapid exchange (Trudell and Hubbell, 1976), in
which the characteristic time needed for the fluorinated molecules to
relocate from one environment to another is significantly shorter than the
reciprocal of the maximum frequency differences for different environ-
ments, the measured peak positions are weighted averages of the limiting
chemical shifts that are characteristic of each nuclear environment. In a
simplified two-site exchange model (Kaneshina et al., 1981; Xu et al.,
1996; Yoshida et al., 1989), in which the lipid membrane is collectively
taken as one site and the aqueous phase as the other, the measured
frequency of a peak, v, is given by (Fraenkel et al., 1990; Xu et al., 1996)
V = XMVM + (1 - XM)VW, (1)
where VM and vw are the limiting frequencies of the same resonance in pure
membrane and in water, respectively, and XM is the molar fraction of the
fluorinated molecule in the membrane. Assuming that Dw and DM are the
solubilities expressed in molar ratio of the dissolved fluorinated molecule
to water and to membrane, respectively, and m and mw are the molarities
of PC and water (a H20 and D20 mixture) in the NMR tube, respectively,
then
XM =mwDw + mDM (2)
Substituting Eq. 2 into Eq. 1 and expressing the frequency difference, A v,
as v
-vw (where vw is measured in the PC-free solution), one has
mDM
mwDw + mDM
Note that the sign of Av is determined by the sign of VM
-Vw. A negative
Av for a given peak indicates that the frequency change in membrane is
upfield relative to the corresponding peak in water.
In the present study, because a 1:4 (v/v) mixture of D20:H20 was used
for the deuterium lock, mw was -54.4 X 103 mM. Thus Eq. 3 can be
rewritten as
1 1 54.4 X 103 1
AV VM VW[ DM/Dw mJ. (4)
If the assumption of a two-phase fast exchange between membrane and
water is valid, then a plot of I/Av as a function of 1/m (m expressed in mM)
will yield a straight line, with the reciprocal of a slope proportional to
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DM/DW and an intercept of 11(vM
-VW). Note that for Av < 0 (upfield
shift), the slope should be negative if the two-site exchange model applies.
A slightly more complicated situation may be considered where the
lipid membrane is further divided into two sites. Thus, for a three-site
model, Eq. 1 becomes
V = XMIVM, + XM2VM2 + (1 - XM, - XM2)VW, (5)
where VMI and VM2 are the hypothetical limiting frequencies of the resonant
peaks at fractional membrane site 1 and site 2, respectively, and XMl and
XM2 are the molar fractions of the fluorinated molecule at these sites.
Clearly, XM = XMI + XM2-
A special case may be considered. Assuming that the molarity of the
two fractional membrane sites equals the molarity of the lipids, and the
solubilities of a fluorinated compound in regions comprising the two sites,
DM I and DM2, respectively, are independent of the lipid concentration, then
the Av - m relationship of the three-site exchange model can be reduced
to an apparent water-membrane two-site exchange model. Indeed, it is
straightforward to show that Eq. 5 can be rewritten in this special case as
1 =I mwDw1
A\V Dm,(VM - VW) + DM2(VM2 VW)l m (6)
DM, +DM2
+ DM,(vM, - VW) + DM2(VM2 VW)
Again, Av = v -vw (i.e., relative to the corresponding peaks in water). If
we define a total solubility in membrane: DM = DM1 + DM2, and an
apparent limiting frequency in membrane: VM = (DM1 VMl + DM2 VM2)/
(DMI + DM2), then Eq. 6 becomes Eq. 4. In other words, if a molecule is
in fast exchange among all three sites and its solubility (or affinity) at the
two fractional sites in membrane is independent of the lipid concentration,
then a two-site exchange model, with the membrane taken collectively as
one site, is as good as a three-site model. Clearly, this result can be
generalized to one aqueous site and multiple membranous sites.
Another special case is when the solubility of a fluorinated molecule in
regions comprising the two membrane sites varies with the lipid concen-
tration. In this case, dependence of XM (or XMl and XM2) on m is more
complicated than as indicated explicitly by Eq. 2, because DM1 and DM2 are
also functions of m. Rearranging Eq. 5 to express frequency change relative
to vw, one has
AV = V- VW = XM(VM2 - VW) + XM,(VMIM VM2). (7)
This equation indicates that the measured frequency change relative to vw
is a weighted superposition of the frequency difference between water and
one of the two membrane sites (the first term in Eq. 7), and the difference
between the two membrane sites (the second term in Eq. 7).
If in the presence of lipids, the membrane sites are strongly favored by
a given fluorinated compound, then XM -' 1, and Eq. 7 can be approxi-
mated by
V - VM2 XM(VM - VM2). (8)
Note the resemblance of Eq. 8 to Eq. 3. This equation describes a two-site
exchange within the membrane, without involving the aqueous phase.
RESULTS
Spectral assignment
Representative NMR spectra of isoflurane in a PC-free
solution, and of neat F3, F6, and F8 are shown in Fig. 1. The
spectral assignment for isoflurane has been well docu-
mented (Dubois and Evers, 1992; Mills et al., 1987; Xu et
in Fig. 1 were based on theoretical consideration of through-
bond shielding and through-space deshielding to the 19F
nuclei by the Cl electron clouds (Cavalli, 1976; Feeney et
al., 1966; Williamson and Braman, 1967) and were con-
firmed by the ratio of peak integration for the trans and cis
forms of F6 and by 19F homonuclear decoupling spectros-
copy. The same number of peaks, with a similar spectral
pattern, was found for fully dissolved F3, F6, and F8 in
water. No additional peaks were found when the PC con-
centration was varied, suggesting that all of the compounds,
once completely dissolved, were either in a single environ-
ment or in rapid exchange among multiple environments.
Changes in resonance frequencies as a function
of PC concentration
Changes in resonant frequencies of all peaks were refer-
enced to the corresponding peaks of the same compound in
a PC-free solution. In the case of multiplets, the midpoints
were used to measure the resonant frequency, so that errors
due to variation in J-coupling constants at different PC
concentrations were minimized. Fig. 2 a compares the fre-
quency changes as a function of PC concentration at 20°C
of various spectral peaks in the anesthetic and nonanesthetic
pair F3 and F6. Similar changes for isoflurane and F8 are
depicted in Fig. 2 b. Note that for both anesthetics (F3 and
isoflurane), changes in frequency as a function of lipid
concentration were gradual. In particular, the frequency
change of the -CF3 resonance in isoflurane was minute over
the range of PC concentrations studied. In contrast, for both
of the nonanesthetics, especially the 19F atoms vicinal to Cl
in F6 (i.e., Faa, Fbb, Fcc, and Fdd, Fig. 1) and those of the
various -CF3 groups and the Fa group in F8, there were
abrupt changes in resonant frequencies when the PC con-
centration was varied from zero to a nonzero value. This
finding suggested that once the PC was present, the non-
anesthetics F6 and F8 were predominantly in the lipid
phase.
Submolecular distribution
The data presented in Fig. 2, a and b, are replotted in Fig. 3
to show the dependence of IlAv on 1/m. Because Av is
unchanged (Av = 0) for the -CF3 resonance of isoflurane,
the double-reciprocal plot cannot be made for this group.
Solid lines are linear least-squares fits to the data using Eq.
4, yielding DM/DW and 1(vM - vw) values (at 20°C) for all
of the resonance peaks of F3 and the -CF2H peak of isoflu-
rane. Similar linear lAv - 1/rm plots are also constructed
(not shown) for F3 and isoflurane at 37°C. The fitting
results are summarized in Table 1. The excellent fit to the
anesthetic data by Eq. 4 suggests that the two-site exchange
model is reasonably realistic for both the linear and cyclic
anesthetics used in this study. Although the Fcis and Frans
peaks of F6, and the FbFc peak of F8 showed a linear
alAv 1/nm dependence, with the same sign of slope as
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FIGURE 1 Representative '9F NMR spectra at 9.4 T (377.4 MHz) and molecular structures of (A) F3, (B) F6, (C) isoflurane, and (D) F8. Labels for F
atoms are indicated in the structures and are used for the peak assignments shown here and in the text.
predicted by Eq. 4, the majority of resonance peaks of these
two nonanesthetics deviated greatly from the water-mem-
brane exchange model (i.e., they either have a wrong slope,
or do not fit a straight line). This is also the case at 37°C.
Because F6 and F8 are small molecules, it is unlikely that
portions of the nonanesthetic molecules are in fast exchange
between membrane and water, whereas the rest of the mol-
ecules are not. Thus a model of two-site exchange between
water and membrane is not applicable to the nonanesthetic
distribution.
As suggested by Eq. 8, the double reciprocal dependency
of resonant frequencies of F6 and F8 on PC concentration
reflects the fast exchange of the nonanesthetics between the
two fractional membrane sites. However, the complexity of
the XMI-m relationship, as implicated by the nonlinear dou-
ble reciprocal function for most of the resonance peaks,
precludes a quantitative analysis of DMl and DM2. For those
nonanesthetic resonances that can be fitted with a linear
function, the reciprocal of the intercept, which equals vMl-
VM2 according to Eq. 8, and the reciprocal of the slope,
which relates in a rather complicated way to the partitioning
of the nonanesthetics at the two membrane sites, are listed
in Table 2.
DISCUSSION
The results presented here show that a novel pair of cy-
clobutanes, one anesthetic and one not, exhibit different
distributions in a model membrane. Two linear compounds,
again, one anesthetic and one not, follow the same patterns
of anesthetic and nonanesthetic distribution. For the anes-
thetics (F3 and isoflurane), resonance from all 19F spins
showed a gradual change in resonant frequency from a
PC-free aqueous solution to vesicle suspensions of various
PC concentrations, suggesting that all 19F spins, and hence
the whole molecules, remained in contact with the aqueous
phase and could exchange easily between the water and
lipid environments. Indeed, results from all resonance peaks
of F3 and the -CHF2 resonance of isoflurane showed an
excellent agreement with the two-site exchange model. The
DM/Dw ratios for these two compounds are in line with
those found by others for other inhaled anesthetics (e.g.,
halothane, enflurane, methoxyflurane, and chloroform),
confirming that the anesthetics dwell in regions close to the
lipid-water interface (Kamaya et al., 1981; Kaneshina et al.,
1981; Xu and Tang, 1997; Yokono et al., 1981, 1989;
Yoshida et al., 1989). Interestingly, the resonant frequency
CF3
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FIGURE 2 Changes in resonant frequencies (Hz at 9.4 T) as a function
of PC concentration at 20°C for (a) compound F3 (Fa, 0; Fb, *; Fc, +) and
compound F6 (FciS, O; Ftrans, 0; Faa, X; Fbb, V; Fcc, A; Fdd, 0); and (b)
isoflurane (-CF2H, A; -CF3, V) and compound F8 (CF3, [SI; CF3/CF3, +;
CFd3, 0); Fa, El; FWFC, ED). All changes are referenced to the corresponding
resonance of the same peak in a PC-free solution (the points at the origin).
The solid lines are a nonlinear regression to the anesthetic data using Eq.
3. The dotted lines are a visual guide for the nonanesthetic data.
of the -CF3 peak of isoflurane did not change with PC
concentration. It has been pointed out (Kaneshina et al.,
1981; Yoshida et al., 1989) that many linearly shaped ha-
logenated anesthetics are amphiphilic, with one end being
relatively more hydrophilic and the other end more hydro-
phobic. It is thus of interest to compare the changes in
resonance frequency of the -CF3 resonance in halothane
(CF3CClBrH) and in isoflurane. The -CF3 group in halo-
thane represents the hydrophobic end of the molecule and
has been shown (Yoshida et al., 1989) to be immersed in the
0.5
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b
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N
I
p
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FIGURE 3 Plot of reciprocal of frequency changes, Av- ', as a function
of reciprocal of PC concentration, [PC]- m-1', for (a) anesthetics F3
and isoflurane; and (b) nonanesthetics F6 and F8. Symbol assignments are
the same as in Fig. 2. Solid lines in a are linear least-squares fit to Eq. 4,
showing an excellent agreement of the anesthetic data with the model of
rapid exchange of the anesthetics between aqueous and membranous
environments. The same model fails to fit the nonanesthetic data. In b,
dashed lines are a linear fit with Eq. 8, and dotted lines, showing nonlin-
earity, are a visual guide.
membrane with the opposite end extending outward, mak-
ing the halothane molecule perpendicular to the membrane
surface. In isoflurane, however, the -CF3 group belongs to
the more hydrophilic end of the molecule. The nearly con-
stant resonant frequency, independent of the lipid concen-
tration, suggests either that the limiting shifts in water and
at the membrane surface are incidentally identical for this
group, or that the -CF3 is in close contact with the aqueous
phase in the vesicle suspension.
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TABLE I Summary of DM/Dw and VM - Vw of F3 and isoflurane at 200C and 370C
200C 370C
Compound F atom DM/Dw X 10-3 VM- vw (Hz) DM/Dw X 10-3 VM- vw (Hz)
Isoflurane CHF2 3.3 ± 0.3 520 + 22 3.2 ± 0.3 433 ± 18
F3 Fa 3.0 ± 0.3 66 ± 3 1.9 0.3 44 5
Fb 2.9±0.2 199±8 2.5±0.2 155±5
FC 2.9 0.4 156 11 2.4 0.2 132 8
TABLE 2 Summary of 1/slopes and (vMl - vM2) of the double-reciprocal plots for F6 and F8
200C 370C
Compound F atom 1/Slope VMI - VM2 (Hz) 1/Slope VMI - VM2 (Hz)
F6 Ftran 24.9 1.2 138 ±6 15.4 ± 1.0 124 ± 7
F,is 43.3 ± 1.2 171 ± 6 31.3 ± 1.4 155 ± 5
F8 Fb,FC 77.8±8.0 122 1 47.6±7.4 96±3
Although the two-site exchange model fits the anesthetic
data well, our results do not contradict the possibility that
multiple membrane sites exist for anesthetics. As Eq. 6
indicates, if the anesthetic distribution among these sites is
independent of the lipid concentration, then the result of fast
exchange among two or more membrane sites is effectively
the same as taking the membrane as a single collective site
(compare Eq. 6 with Eq. 4). Using 2H NMR and 'H-1H
NOE spectroscopy, Baber and colleagues showed in a re-
cent study (Baber et al., 1995) that the anesthetic effects on
the order parameter for segments 1-6 and segments 7-16 in
a perdeuterated palmitoyl(d31)oleoylphosphatidylcholine
(POPC-d3l) membrane were different, suggesting that seg-
ments 1-6 and 7-16 may represent different sites for anes-
thetic binding. A careful examination, by the same authors,
of the average population of anesthetics at these sites re-
vealed that the fractional occupations at these two sites were
almost equal, with a slight preference of anesthetics for the
interface. Because the linear IlAv - /rm relationship fulfills
both Eq. 4 and Eq. 6, our result with F3 and isoflurane
further confirms that the anesthetics are in rapid exchange
not only between aqueous and membranous phases, but also
among submolecular sites within the lipid membrane
(Trudell and Hubbell, 1976).
The situation, however, was entirely different for the
nonanesthetics. For both F6 and F8, most resonance peaks
could not be approximated by the two-site exchange model
(see Figs. 2 a, 2 b, and 3 b). Almost all spins showed abrupt
changes in resonant frequency from the aqueous phase to
the lipid membrane. Such abrupt changes indicate that the
molecular environments for these spins are completely dif-
ferent when changing from the aqueous phase to the lipid
phase-once the lipid is present, the chance that these spins
will approach water is greatly reduced. Because F6 and F8
are small in size, this result also implies that the accessibil-
ity of whole nonanesthetic molecules to the aqueous phase
may be limited.
This conclusion is also qualitatively in agreement with
Eqs. 7 and 8. A close examination of the data for F6 and F8
in Fig. 2, a and b, especially those with negative A v, reveals
that the frequency changes of the nonanesthetics can all be
treated as a superposition of a large, abrupt jump relative to
Vw and a small change over the range of the PC concentra-
tion studied. Clearly, the large jump can be accounted for by
the first term in Eq. 7, whereas the small increases are
dictated by the second term of Eq. 7. Thus, if the nonanes-
thetics do indeed escape from the aqueous phase when PC
is present, then it is conceivable, according to Eq. 8, that the
small frequency change after the abrupt jump is due to the
two-site exchange process of nonanesthetics inside the
membrane, probably within the core of the lipid bilayer
without involving the water phase.
Temperature had only small effects on the anesthetic and
nonanesthetic distribution in the egg PC membrane. As the
temperature was increased from 20°C to 37°C, the DM/DW
and VM- vw of the two anesthetics, and the slopes and
intercepts of the double-reciprocal plots for the two non-
anesthetics were all decreased slightly (see Table 1 and
Table 2). The overall distribution pattern, however, re-
mained the same: the anesthetics dwelled in regions closer
to the aqueous phase, whereas the nonanesthetics parti-
tioned deeply into the membrane.
The distinct distribution of anesthetics and nonanesthetics
may ultimately affect their affinity for other membrane
constituents, such as membrane proteins. Although the lipid
portions of membranes have been implicated by the Meyer-
Overton rule as the target sites for general anesthetics,
recent evidence suggests that anesthetics may inhibit neu-
ronal activity by modulating the function of specific pro-
teins. A superfamily of neurotransmitter-gated receptor
channels, including the y-aminobutyric acidA (GABAA)
receptor, the glycine receptor, the neuronal and muscular
nicotinic acetylcholine receptor, and 5-hydroxytryptamine3
receptor, are particularly sensitive to general anesthetics
(Wood et al., 1995), with potentiation of postsynaptic in-
hibitory channel activity best fitting the pharmacological
profile of general anesthesia (Franks and Lieb, 1994). In-
deed, it has been shown (Mihic et al., 1994) that F3, but not
1681Tang et al.
1682 Biophysical Journal Volume 72 April 1997
F6 and F8, can strongly potentiate GABAergic currents in
Xenopus oocytes expressing a1f32 or alf32,y2S GABAA
receptors. Because a structurally diverse range of anesthet-
ics can enhance the same current, but structurally compa-
rable nonanesthetics cannot, the anesthetic action at these
receptors must not be structurally specific. Rather, it may
simply be controlled by the submolecular solubility to some
amphipathic sites on the protein: the strong hydrophobicity
of the nonanesthetics, as shown in this study, renders them
less likely to distribute to these sites.
In conclusion, we have shown that the distributions of
anesthetics and nonanesthetics in the membrane differ. The
anesthetics dwell in the more amphiphilic regions with easy
access to the aqueous phase, whereas the nonanesthetics
prefer the lipid core of the membrane.
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